Literature DB >> 30908162

Resilience and Beliefs in the Effectiveness of Current Antiretroviral Therapies Among Recently Disengaged Low-Income People of Color Living with HIV.

J Jaiswal1,2,3, S N Singer1,4, H-M Lekas5,6.   

Abstract

Consistent antiretroviral adherence is key to viral suppression, but many low-income people of color living with HIV are not optimally adherent due to a wide variety of interrelated social and structural factors. Previous studies have found that HIV medication beliefs are an important facet of adherence. In contrast to the AZT era , currently available antiretroviral therapies are significantly safer and more effective, but research suggests that negative beliefs may persist among racial and ethnic minority people. Twenty-seven semi-structured interviews were conducted with low-income Black and Latinx people living with HIV in New York City that were currently, or had been recently, disengaged from outpatient HIV medical care. This research suggests that socially and economically marginalized people living with HIV, many long-term survivors who lived through the AZT era, recognized that current treatments are very effective in making HIV a chronic, manageable illness and a significant improvement compared to the therapies early in the epidemic. Most importantly, the data suggests that people demonstrate great resilience despite their experiences of social and economic exclusion. Both clinical practice and public health interventions can benefit from these findings. HIV care providers should speak with patients about their beliefs related to HIV medication, and public health interventions should specifically address HIV medication-related beliefs in order to enhance adherence. In order to avoid reifying people's marginalization, public health should endeavor to recognize and support people's resilience.

Entities:  

Keywords:  ART adherence; ART beliefs; HIV care; HIV medication; resilience

Mesh:

Substances:

Year:  2019        PMID: 30908162      PMCID: PMC7549317          DOI: 10.1080/08964289.2019.1570070

Source DB:  PubMed          Journal:  Behav Med        ISSN: 0896-4289            Impact factor:   3.104


  47 in total

Review 1.  Concept analysis: resilience.

Authors:  Mary Joy Garcia-Dia; Jean Marie DiNapoli; Leila Garcia-Ona; Rita Jakubowski; Deirdre O'Flaherty
Journal:  Arch Psychiatr Nurs       Date:  2013-09-24       Impact factor: 2.218

2.  Resilience as an untapped resource in behavioral intervention design for gay men.

Authors:  Amy L Herrick; Sin How Lim; Chongyi Wei; Helen Smith; Thomas Guadamuz; Mark S Friedman; Ron Stall
Journal:  AIDS Behav       Date:  2011-04

3.  Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel.

Authors:  Melanie A Thompson; Michael J Mugavero; K Rivet Amico; Victoria A Cargill; Larry W Chang; Robert Gross; Catherine Orrell; Frederick L Altice; David R Bangsberg; John G Bartlett; Curt G Beckwith; Nadia Dowshen; Christopher M Gordon; Tim Horn; Princy Kumar; James D Scott; Michael J Stirratt; Robert H Remien; Jane M Simoni; Jean B Nachega
Journal:  Ann Intern Med       Date:  2012-03-05       Impact factor: 25.391

4.  Diminishing Perceived Threat of AIDS and Increasing Sexual Risks of HIV Among Men Who Have Sex with Men, 1997-2015.

Authors:  Seth C Kalichman; Devon Price; Lisa A Eaton; Kaylee Burnham; Matthew Sullivan; Stephanie Finneran; Talea Cornelius; Aerielle Allen
Journal:  Arch Sex Behav       Date:  2017-02-06

5.  Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients.

Authors:  Angela D Thrasher; Jo Anne L Earp; Carol E Golin; Catherine R Zimmer
Journal:  J Acquir Immune Defic Syndr       Date:  2008-09-01       Impact factor: 3.731

6.  Combating HIV stigma in health care settings: what works?

Authors:  Laura Nyblade; Anne Stangl; Ellen Weiss; Kim Ashburn
Journal:  J Int AIDS Soc       Date:  2009-08-06       Impact factor: 5.396

7.  The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

Authors:  D D Richman; M A Fischl; M H Grieco; M S Gottlieb; P A Volberding; O L Laskin; J M Leedom; J E Groopman; D Mildvan; M S Hirsch
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

8.  The impact of anticipated HIV stigma on delays in HIV testing behaviors: findings from a community-based sample of men who have sex with men and transgender women in New York City.

Authors:  Sarit A Golub; Kristi E Gamarel
Journal:  AIDS Patient Care STDS       Date:  2013-10-18       Impact factor: 5.078

Review 9.  HIV prevention, structural change and social values: the need for an explicit normative approach.

Authors:  Justin O Parkhurst
Journal:  J Int AIDS Soc       Date:  2012-06-14       Impact factor: 5.396

10.  The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS.

Authors:  Jennifer N Sayles; Mitchell D Wong; Janni J Kinsler; David Martins; William E Cunningham
Journal:  J Gen Intern Med       Date:  2009-08-04       Impact factor: 5.128

View more
  2 in total

1.  Racial disparities in the association between resilience and ART adherence among people living with HIV: the mediating role of depression.

Authors:  Monique J Brown; Miao Wu; Chengbo Zeng; Sayward Harrison; Mohammad Rifat Haider; Xiaoming Li
Journal:  AIDS Care       Date:  2022-03-07

2.  "Worn out": Coping strategies for managing antiretroviral treatment fatigue among urban people of color living with HIV who were recently disengaged from outpatient HIV care.

Authors:  J Jaiswal; M D Francis; S N Singer; K B Dunlap; A B Cox; R Greene
Journal:  J HIV AIDS Soc Serv       Date:  2020-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.